Drug Reference
Donepezil / Memantine
Anticholinesterases
Fact box
- Therapeutic class
- Anticholinesterases
Brand names
Namzaric
Available as
10 MG · Extended Release Oral Capsule
Multi-ingredient product
DonepezilMemantine
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Current FDA labels (DailyMed)
- NAMZARIC (MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE) CAPSULE NAMZARIC (MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE) KIT [ALLERGAN, INC.]
- MEMANTINE AND DONEPEZIL CAPSULE, EXTENDED RELEASE [MACLEODS PHARMACEUTICALS LIMITED]
- MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [VITRUVIAS THERAPEUTICS, INC.]
- MEMANTINE AND DONEPEZIL HYDROCHLORIDES EXTENDED-RELEASE (MEMANTINE AND DONEPEZIL) CAPSULE, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS NY LLC]
- MEMANTINE AND DONEPEZIL HYDROCHLORIDES EXTENDED-RELEASE (MEMANTINE AND DONEPEZIL) CAPSULE, EXTENDED RELEASE [AVKARE]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.